Lilly to Establish an Access Program for Patients as it Prepares to Withdraw Lartruvo from the Global Market

By In The News
April 25, 2019 in The Headlines

Recommended Posts

In The News

Posted April 25, 2019

- Share

Posted April 25, 2019

INDIANAPOLIS, April 25, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the company has been working to facilitate the withdrawal of Lartruvo® (olaratumab) from the market for the treatment of advanced soft tissue sarcoma (STS). Lilly's actions to withdraw...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222008
2. Jaydee
  17783
3. deicer
  13345
4. Kip Powick
  12311
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.4k
- Total Posts
  
  565k

Sign In

Lilly to Establish an Access Program for Patients as it Prepares to Withdraw Lartruvo from the Global Market

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support